Non-invasive histologic markers of liver disease in patients with chronic hepatitis B. - Wikidata - wikimedia - TriplyDB

Non-invasive histologic markers of liver disease in patients with chronic hepatitis B.

Non-invasive histologic markers of liver disease in patients with chronic hepatitis B.

http://www.wikidata.org/entity/Q37631624

about

Negative Association of Plasma Levels of Vitamin D and miR-378 With Viral Load in Patients With Chronic Hepatitis B Infection Low Serum Hepatitis B Surface Antigen Level Predicts Compensated Cirrhosis Caused by Chronic Hepatitis B in HBeAg Positive Patients in East China.Red blood cell distribution width levels correlate with liver fibrosis and inflammation: a noninvasive serum marker panel to predict the severity of fibrosis and inflammation in patients with hepatitis B.Noninvasive scoring system for significant inflammation related to chronic hepatitis B.Aspartate aminotransferase to platelet ratio index - a reliable predictor of therapeutic efficacy and improvement of Ishak score in chronic hepatitis B patients treated with nucleoside analogues.

P2860

Q35942365-4201777B-3C57-42C8-B20E-3B9EFE241D3F Q35988296-649AC148-EBAD-463C-8FB6-C36529538864 Q36151026-53735DD8-521D-4AA6-B357-E471B1004156 Q37692297-F0616D5B-17BD-40B5-ABA2-222A2C13538A Q40790849-D4A92E6E-03A6-4584-91DB-674D2B5E13F9

P2860

Non-invasive histologic markers of liver disease in patients with chronic hepatitis B.

http://www.wikidata.org/entity/Q37631624

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 28 February 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Non-invasive histologic markers of liver disease in patients with chronic hepatitis B.

@en

Non-invasive histologic markers of liver disease in patients with chronic hepatitis B.

@nl

type

label

Non-invasive histologic markers of liver disease in patients with chronic hepatitis B.

@en

Non-invasive histologic markers of liver disease in patients with chronic hepatitis B.

@nl

prefLabel

Non-invasive histologic markers of liver disease in patients with chronic hepatitis B.

@en

Non-invasive histologic markers of liver disease in patients with chronic hepatitis B.

@nl

P1433

Q37631624-DDC2E060-B589-4F76-95F8-D379FF52FC80

P1476

Q37631624-6EB31FFD-387B-4259-AC86-1D010B00DC44

P2093

Q37631624-9B7AEABA-ED72-4D33-BF8E-3D9A4622C328

P2860

Q37631624-08497CE7-ED0D-4E0D-91FA-2E2CCC7CCD09

Q37631624-1861F14E-B659-4B05-8681-FE51382A9E02

Q37631624-1D819482-C842-42CE-B5DA-C1831A24AEE4

Q37631624-246BD2D9-8638-4ADF-9A15-642264836E8F

Q37631624-34BDE622-4E2A-4C67-A20E-7E24C4FB6177

Q37631624-3DDD77E2-D504-4EF0-8DE6-BC809829CA8C

Q37631624-419DC926-B48C-44E4-88FE-7EFE0F844ECC

Q37631624-6576E226-CF8B-40BE-B899-96E951D7222E

Q37631624-67D3063D-B7E9-468E-9A53-AF09B001A950

Q37631624-76A7A921-89A9-4FDA-BE90-52F3E5DD8748

P304

Q37631624-00C6B6A9-D62F-4E09-A79A-2CD13ADAC14B

P31

Q37631624-A079B57D-9DF6-40D7-9D8F-749BE41DCF1F

P356

Q37631624-6FCB7381-C0CF-4894-A323-E1F32D4368E7

P407

Q37631624-67A06468-8651-466A-B3D8-28D03299054F

P433

Q37631624-0DD0D818-0160-49A7-8677-80BD1EC0C72C

P478

Q37631624-DDF65FE1-C1F5-4F44-986D-DBE6FD4D6ED7

P50

Q37631624-59D28606-FCA5-4E91-BBB5-246A47D5F2E8

Q37631624-64F7A536-03AC-4057-B097-182941381B3B

Q37631624-74BF51E3-8584-4EAA-BE1D-9941D3E96B90

P577

Q37631624-B551B54F-F99C-407C-8706-CD43B9F568B6

P5875

Q37631624-974FFEC5-CF54-488F-BA25-C28E0AC0BC8A

P698

Q37631624-7B5A98A2-194C-4483-A2BA-3F8B8CFE8C50

P932

Q37631624-562AA73A-70A6-40F5-AD09-F4BDED158D0C

P356

P1433

Hepatitis Monthly

P1476

Non-invasive histologic markers of liver disease in patients with chronic hepatitis B

@en

P2093

Mehdi Karamipour

http://www.w3.org/2001/XMLSchema#string

P2860

A new model using routinely available clinical parameters to predict significant liver fibrosis in chronic hepatitis B

Histological grading and staging of chronic hepatitis

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

Chronic hepatitis B virus infection in Asian countries.

Comparisons of noninvasive indices based on daily practice parameters for predicting liver cirrhosis in chronic hepatitis B and hepatitis C patients in hospital and community populations.

The natural history and treatment of chronic hepatitis B: a critical evaluation of standard treatment criteria and end points.

Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis B-related fibrosis: a leading meta-analysis.

Is day case liver biopsy underutilised?

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.

Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis [Hepatology 1981;1:431-435].

P304

e14228

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5812/HEPATMON.14228

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Simin Dokht Shoaei

P577

2014-02-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261295357

http://www.w3.org/2001/XMLSchema#string

P698

24693307

http://www.w3.org/2001/XMLSchema#string

P932

3950569

http://www.w3.org/2001/XMLSchema#string